Search

everythinglearnresearchcommunity

for

Search:↓

FERONIA regulates plant growth, pollen interactions, and sugar signaling.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

Araliadiol may help reduce skin aging and inflammation without killing cells.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

The inhibitor affects androgen metabolism but not ovarian function.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Adiantum capillus-veneris may help with respiratory issues, but more research is needed.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

Extracellular ATP promotes growth, while adenosine inhibits it in Arabidopsis plants.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Radiesse is a versatile facial injectable used for cosmetic improvements and long-term collagen production, with careful dosing needed to prevent complications.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Anabolic agents can cause cardiovascular and behavioral issues in athletes.

Blocking certain immune signals can reduce skin damage from radiation therapy.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

HAIR-AN syndrome mainly affects obese women and can be improved with early diagnosis and treatment using insulin-sensitizing agents.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

AGD1's PH domain is essential for its role in root hair growth and polarity.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

Analog 23 is a promising compound for prostate cancer treatment.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

The study found that combining different databases gives a better estimate of drug side effects in hospitals.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

ERULUS is crucial for root hair growth by controlling calcium levels.